Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lutz

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Journal of Palliative Medicine|September 5, 2014
Availability of single-fraction palliative radiotherapy for cancer patients receiving end-of-life care within the Veterans Healthcare AdministrationDrew Moghanaki, Alice V Cheuk, Helen Fosmire, et al.
Letters in Applied Microbiology|July 3, 2020
A CRISPR-Cas9 tool to explore the genetics of Bacillus subtilis phagesK Otte, N M Kühne, A D Furrer, et al.
Transplantation Proceedings|April 21, 2015
Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case reportJ D Hart, C T Lutz, C D Jennings, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1990
The diagnostic utility of immunophenotyping and immunogenotyping in the pathologic evaluation of lymphoid proliferationsD Kamat, M J Laszewski, J D Kemp, et al.
Journal of the National Cancer Institute|February 19, 1997
Medical history risk factors for non-Hodgkin's lymphoma in older womenJ R Cerhan, R B Wallace, A R Folsom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2011
Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adultsCharles T Lutz, Anush Karapetyan, Ahmad Al-Attar, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2009
Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patientsM Bickel, A Bodtländer, G K Knecht, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1996
Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovaniH Albrecht, I Sobottka, C Emminger, et al.
Journal of Dairy Science|April 5, 2001
Determination of acetone in cow milk by Fourier transform infrared spectroscopy for the detection of subclinical ketosisC Heuer, H J Luinge, E T Lutz, et al.
Environmental Microbiology|March 16, 2022
The Bacillus phage SPβ and its relatives: a temperate phage model system reveals new strains, species, prophage integration loci, conserved proteins and lysogeny management componentsKatharina Kohm, Valentina A Floccari, Veronika T Lutz, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Journal of Palliative Medicine|September 5, 2014
Availability of single-fraction palliative radiotherapy for cancer patients receiving end-of-life care within the Veterans Healthcare AdministrationDrew Moghanaki, Alice V Cheuk, Helen Fosmire, et al.
Letters in Applied Microbiology|July 3, 2020
A CRISPR-Cas9 tool to explore the genetics of Bacillus subtilis phagesK Otte, N M Kühne, A D Furrer, et al.
Transplantation Proceedings|April 21, 2015
Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case reportJ D Hart, C T Lutz, C D Jennings, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1990
The diagnostic utility of immunophenotyping and immunogenotyping in the pathologic evaluation of lymphoid proliferationsD Kamat, M J Laszewski, J D Kemp, et al.
Journal of the National Cancer Institute|February 19, 1997
Medical history risk factors for non-Hodgkin's lymphoma in older womenJ R Cerhan, R B Wallace, A R Folsom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2011
Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adultsCharles T Lutz, Anush Karapetyan, Ahmad Al-Attar, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2009
Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patientsM Bickel, A Bodtländer, G K Knecht, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1996
Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovaniH Albrecht, I Sobottka, C Emminger, et al.
Journal of Dairy Science|April 5, 2001
Determination of acetone in cow milk by Fourier transform infrared spectroscopy for the detection of subclinical ketosisC Heuer, H J Luinge, E T Lutz, et al.
Environmental Microbiology|March 16, 2022
The Bacillus phage SPβ and its relatives: a temperate phage model system reveals new strains, species, prophage integration loci, conserved proteins and lysogeny management componentsKatharina Kohm, Valentina A Floccari, Veronika T Lutz, et al.
Pageof 18